Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152478 | SCV000201604 | uncertain significance | not specified | 2014-04-10 | criteria provided, single submitter | clinical testing | The Thr3295Met variant in TTN has not been reported in individuals with cardiomy opathy, but has been identified in 1/120 Colombian chromosomes by the 1000 Genom es Project (dbSNP rs191708454). Threonine (Thr) at position 3295 is not well con served in evolution and 1 mammalian species (squirrel) carries the variant amino acid (Met), raising the possibility that this change may be tolerated. Addition al computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhe n2, and SIFT) do not provide strong support for or against an impact to the prot ein. Additional information is needed to fully assess the clinical significance of this variant. |
Gene |
RCV001719943 | SCV000238071 | likely benign | not provided | 2020-07-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000540226 | SCV000643999 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293078 | SCV001434061 | uncertain significance | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Revvity Omics, |
RCV001719943 | SCV003820252 | uncertain significance | not provided | 2021-01-19 | criteria provided, single submitter | clinical testing |